Elcid Investments has experienced a staggering share price surge of 66,92,535%, reaching a value of ₹2,36,250, making it India's most expensive stock, surpassing MRF. The stock initially traded at ₹3.21 in July 2024, and a ₹10,000 investment at that time would now be worth approximately ₹70 crore. The company also declared a dividend amounting to 708% of its share price. In other market movements, shares of NHPC rose 2.92% to ₹82.93, Gala Precision Engineering surged 17% to a record high of ₹1,105.45, and CRISIL shares increased 4.44% to a 52-week high of ₹5,435. UTI AMC shares hit a record high of ₹1,349.60, while Biocon's Q2FY25 net profit declined 84% year-on-year to ₹27 crore, despite a revenue increase to ₹3,590.4 crore. Cipla shares jumped over 10% following a US FDA classification of its Goa facility as Voluntary Action Indicated.